SPDR STOXX Europe 600 SRI UCITS ETF EUR Acc (EUR) | 600XRegister to Unlock Ratings |
Performance History | 30/11/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 3.6 | 18.4 | -7.0 | 16.6 | 7.0 | |
+/-Cat | -0.8 | 3.1 | 1.3 | 5.0 | 4.5 | |
+/-B’mrk | 1.0 | 0.8 | -2.5 | 3.4 | 2.0 | |
Category: Europe Large-Cap Blend Equity | ||||||
Category Benchmark: Morningstar DM Eur TME NR EUR |
Key Stats | ||
Closing Price 29/11/2024 | EUR 30.87 | |
Day Change | 0.58% | |
Morningstar Category™ | Europe Large-Cap Blend Equity | |
Volume | 1595 | |
Exchange | EURONEXT AMSTERDAM | |
ISIN | IE00BK5H8015 | |
Fund Size (Mil) 29/11/2024 | EUR 305.07 | |
Share Class Size (Mil) 29/11/2024 | EUR 305.07 | |
Ongoing Charge 12/02/2024 | 0.12% |
Investment Objective: SPDR STOXX Europe 600 SRI UCITS ETF EUR Acc (EUR) | 600X |
The investment objective of the Fund is to track the performance of European equities. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
- - | ||
Inception Date 30/09/2019 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
STOXX Europe 600 SRI TR EUR | Morningstar DM Eur TME NR EUR |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for SPDR STOXX Europe 600 SRI UCITS ETF EUR Acc (EUR) | 600X | 31/10/2024 |
|
|
Top 5 Holdings | Sector | % |
Novo Nordisk AS Class B | Healthcare | 7.07 |
ASML Holding NV | Technology | 5.35 |
SAP SE | Technology | 4.72 |
Novartis AG Registered Shares | Healthcare | 4.33 |
Roche Holding AG | Healthcare | 4.32 |
Increase Decrease New since last portfolio | ||
SPDR STOXX Europe 600 SRI UCITS ETF EUR Acc (EUR) | 600X |